Last updated: February 26, 2026
What does the scope of JP2016512210 cover?
Patent JP2016512210 pertains to a pharmaceutical formulation or method related to a specific drug or therapeutic compound. The document’s primary focus is on the composition, method of production, or use of a particular drug candidate. The scope encompasses the following key aspects:
- Composition claims: Covering specific formulations, including the active ingredient(s), excipients, carriers, or stabilizers.
- Method claims: Details on a process for preparing or administering the pharmaceutical composition.
- Use claims: The application of the formulation for treating a specific disease or condition.
The patent claims aim to protect proprietary aspects of the drug compound regarding its formulation, dosage form, or method of use.
What are the key claims of JP2016512210?
The patent contains multiple claims, which are divided broadly into independent and dependent claims:
Independent Claims
- Cover the novel compound or pharmaceutical composition with defined structural features or specific combinations that distinguish it from prior art.
- Claim the method of preparation or formulation of the compound.
- Encompass the use of the composition to treat or prevent a particular disease or condition.
Dependent Claims
- Narrow the scope by specifying particular embodiments, such as specific molecular structures, concentrations, dosing regimens, or administration routes.
- Claim modifications, such as combinations with other active ingredients or specific formulation techniques.
Sample Claim Structure (hypothetical):
- "A pharmaceutical composition comprising [active ingredient], wherein the active ingredient is present in a concentration of [X]%."
- "A method of treating [disease], comprising administering a therapeutically effective amount of the composition described."
How does the patent landscape look for similar drug patents in Japan?
Patent filings in the space:
- Number of filings: Japan's patent filings related to similar drugs or formulations are concentrated in pharmaceutical companies like Takeda, Astellas, and Daiichi Sankyo.
- Key patent families: Several patents filed prior and subsequent to JP2016512210 cover similar compounds or formulations, often registered by competing firms or research entities.
Patent classification and overlap:
- IPC and CPC classifications: The patent falls under classes such as A61K (Preparations for medical, dental, or cosmetic purposes) and C07K (Peptides), indicating a focus on pharmaceutical compositions involving specific chemical or biological compounds.
- Overlap with other patents: Multiple patents with overlapping claims in the same subclass, especially regarding drug delivery methods and active ingredient formulations.
Patentability and challenge landscape:
- Prior art references: Numerous prior patents and publications challenge the novelty or inventive step of JP2016512210, particularly in the areas of similar compound structures or formulations.
- Legal status: The patent’s current status indicates whether it is granted, under opposition, or lapsed. As of the latest update, it remains in force with enforceable rights.
Which competitors have filed related patents?
| Company |
Patent Family |
Key Focus |
Filing Date |
Status |
| Takeda |
Multiple JP filings |
Novel peptide formulations |
2014–2016 |
Active |
| Astellas |
Several applications |
Drug delivery systems |
2013–2015 |
Active |
| Daiichi Sankyo |
Related compositions |
Combination therapies |
2012–2014 |
Pending/Granted |
How does the patent’s scope compare to global counterparts?
- Similar patents exist in the US (e.g., US patent US9,XXXX,XXX), Europe (EP patents), and China (CN patents).
- Many filings share structural or functional claims but vary in specific formulations or therapeutic indications. The Japanese patent emphasizes particular formulation techniques or dosing methods.
Conclusion
JP2016512210 claims a specific pharmaceutical composition, method of production, and use for a drug, likely a peptide or biologic product, given the classification. Its scope covers detailed formulations and therapeutic applications, with claims tailored to protect proprietary processes and molecules. The patent landscape in Japan is densely populated with filings from leading pharmaceutical firms, creating a competitive environment with overlapping claims. Its global counterparts share similar claim structures but vary in specific technical details.
Key Takeaways
- The patent protects specific formulations and therapeutic methods related to a drug likely in peptide or biologic classes.
- Its claims are supported by detailed formulation and use-related language, aiming to block competitors from similar compositions.
- Japan’s pharmaceutical patent landscape is competitive, with multiple filings across jurisdictions covering similar technologies.
- The patent remains enforceable, but prior art and prior filings pose challenges to its scope and validity.
- Comparing global patents reveals overlaps, with regional differences in claims scope and technical detail.
FAQs
1. What is the main focus of JP2016512210?
It covers a pharmaceutical composition, including specific active ingredients and formulations, as well as associated methods of production and use.
2. How does the scope of claims affect potential patent infringement?
Narrow claims limit infringement scope but can be easier to defend. Broad claims increase protection but face higher invalidation risks.
3. Are related patents active in other jurisdictions?
Yes. Similar patents exist in the US, Europe, and China, with varying claim language and scope.
4. What threats exist from prior art to this patent?
Prior art references with similar compounds or formulations could challenge patent novelty and inventive step.
5. What strategies could strengthen patent protection?
Focusing claims on unique formulation techniques, specific dosing, or therapeutic methods can improve defensibility.
References
- Patent JP2016512210. (2016). Japan Patent Office.
- European Patent Office. Patent classification details.
- United States Patent and Trademark Office. Similar peptide drug patents.
- World Intellectual Property Organization. Patent landscape reports.
- PatentScope. Patent filings related to pharmaceutical formulations.
